Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma. [electronic resource]
Producer: 20200420Description: 629-636 p. digitalISSN:- 1569-8041
- Aged
- Biomarkers, Tumor -- analysis
- Chemoradiotherapy -- methods
- Cisplatin -- therapeutic use
- Clinical Decision-Making
- Cyclin-Dependent Kinase Inhibitor p16 -- analysis
- DNA, Viral -- isolation & purification
- Datasets as Topic
- Denmark -- epidemiology
- Female
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Models, Biological
- Neoplasm Recurrence, Local -- epidemiology
- Oropharyngeal Neoplasms -- genetics
- Papillomaviridae -- genetics
- Papillomavirus Infections -- genetics
- Predictive Value of Tests
- Prognosis
- Risk Assessment -- methods
- Squamous Cell Carcinoma of Head and Neck -- genetics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.